Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Gensia Sicor's GenESA System assigned new indication

June 16, 1997

Guilford granted U.S. patent for polymer drug delivery of anticancer agents

June 13, 1997

Arris and Abbott sign licensing agreement

June 12, 1997

Harvard Medical School and Hoechst Marion Roussel enter research agreement

June 12, 1997

ABS forms alliance with Russian Academy of Sciences

June 11, 1997

Antifibrotic collaboration announced by ArQule and FibroGen

June 11, 1997

NitroMed issued U.S. patent covering NO delivery compounds

June 11, 1997

Copernicus Gene Systems and Inex establish gene delivery collaboration

June 9, 1997

Preclinical validation of Techniclone's Vasopermeation Enhancement technology

June 9, 1997

ProScript milestone in inflammatory disease/cancer collaboration triggers payment from HMR

June 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...